Eris Lifesciences Ltd (nse:ERIS) Share Price

Company Profile

Business description
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include LNBloc, Olmin, Eritel, Atorsave and Crevast. Geographically, the company generates key revenue from India followed by International markets operations spanning in Latin America, Africa, Asia-Pacific, the Middle East, and CIS regions.
Contact
Ramdas Road
Plot No. 142/2, Shivarth Ambit
Off SBR, Near Swati Bungalows
Bodakdev
AhmedabadGJ380054
IND
T: +91 7969661000
https://www.eris.co.in
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
3,076

Recommended

We see regulatory risk from both the US and Chinese governments.

Seth Goldstein, CFA | 25 October 2026

Near-term pain, long-term potential.

Dan Baker | 22 October 2026

We see the company’s momentum in its core advertising business, as well as adoption of Muse, as early signals that the firm’s AI playbook is working.

Malik Ahmed Khan, CFA | 22 October 2026

Index	Last price	Change	% Change
All Ordinaries	8,926.60	20.80	0.23%
CAC 40	7,848.37	65.55	0.84%
DAX 40	25,438.40	256.75	1.02%
Dow JONES (US)	52,293.46	78.30	0.15%
FTSE 100	10,758.02	67.66	0.63%
HKSE	23,211.81	118.44	0.51%
NASDAQ	26,195.56	240.22	0.93%
Nikkei 225	62,189.65	503.51	-0.80%
NZX 50 Index	13,733.93	12.91	-0.09%
S&P 500	7,675.55	51.87	0.68%
S&P/ASX 200	8,809.90	14.70	0.17%
SSE Composite Index	3,697.52	7.04	0.19%